The Cell and Gene Therapy Catapult (CGT Catapult) presented the data in its UK 2024 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database. The UK maintained its position as a highly ...

Results of a recent study provided insight into the training needs of nurses involved in the use of advanced therapy medicinal products (ATMPs). The findings were reported in the journal Clinical ...

It also marks the first time that an advanced therapy medicinal product (ATMP) has used an outcomes-based payment model as described in the UK’s voluntary rebate scheme (VPAG). “This agreement ...

The Public Health Ministry has established a committee for monitoring and evaluating advanced therapy medicinal products (ATMPs) to further boost treatment efficiency and offer treatment alternatives ...

Personalised cancer vaccines offer significant potential to address an unmet medical need in treatment-resistant disease with fewer side effects and less toxicity compared to standard treatment ...

As of March 2018, 10 products have received MA in the EU with Chondrocelect ... and FDA's Breakthrough Designation and Regenerative Medicine Advanced Therapy Designation (2017) have been created to ...

The stakeholders of ATMPs recommended to reform of the Hospital Exemption (HE) scheme for Advanced Therapy Medicinal Products (ATMPs) in the legislation. The current ATMP Regulation (EC) No 1394/2007, ...

Take a look overseas, the U.S. market currently counts 43. However, since 2020, the European Medical Agency (EMA) has made notable progress in approving advanced therapy medicinal products (ATMPs) – ...

However, there are challenges, particularly concerning the manufacturing process of this advanced therapy medicinal product (ATMP). Looking ahead, Per-Ola Carlsson suggests moving away from organ ...